Acumen Pharmaceuticals (ABOS) Stock Chart & Stock Price History → Trump’s arrest is phase one (From Porter & Company) (Ad) Free ABOS Stock Alerts $2.94 -0.04 (-1.34%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Acumen Pharmaceuticals Stock Price Performance5 Day Performance-13.53%1 Month Performance-9.54%3 Month Performance-36.64%6 Month Performance+10.94%Year-To-Date Performance-23.44%1 Year Performance-41.20% Receive ABOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. ABOS Stock Chart for Saturday, June, 1, 2024 ABOS Chart by TradingView Acumen Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.98$2.94-1.34%$3.07$2.90371,099 shs$176.64 million05/30/2024$3.05$2.98-2.30%$3.16$2.95396,339 shs$179.04 million05/29/2024$3.25$3.05-6.15%$3.26$3.01319,277 shs$183.24 million05/28/2024$3.40$3.25-4.41%$3.45$3.22243,737 shs$195.26 million05/27/2024$3.40$3.40$3.48$3.28205,100 shs$204.27 million05/24/2024$3.40$3.40$3.48$3.28205,129 shs$204.27 million Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$3.60$3.40-5.56%$3.61$3.33181,670 shs$204.27 million05/22/2024$3.81$3.60-5.51%$3.90$3.60166,643 shs$216.29 million05/21/2024$3.84$3.81-0.78%$3.88$3.68160,562 shs$228.91 million05/20/2024$3.65$3.84+5.21%$3.92$3.65141,612 shs$230.71 million05/17/2024$3.73$3.65-2.14%$3.77$3.5678,219 shs$219.29 million05/16/2024$3.80$3.73-1.84%$3.85$3.7283,446 shs$224.10 million05/15/2024$3.69$3.80+2.98%$3.91$3.60213,566 shs$228.30 million05/14/2024$3.36$3.69+9.82%$3.74$3.39230,521 shs$221.70 million05/13/2024$3.36$3.36$3.50$3.32119,201 shs$201.87 million05/10/2024$3.57$3.36-5.88%$3.65$3.36123,425 shs$201.87 million05/09/2024$3.40$3.57+5.00%$3.64$3.40172,219 shs$214.49 million05/08/2024$3.36$3.40+1.19%$3.60$3.36149,899 shs$204.27 million05/07/2024$3.56$3.36-5.62%$3.61$3.36140,223 shs$201.87 million05/06/2024$3.49$3.56+2.01%$3.65$3.47177,331 shs$213.89 million05/03/2024$3.48$3.49+0.29%$3.71$3.49247,725 shs$209.68 million05/02/2024$3.25$3.48+7.08%$3.48$3.24229,426 shs$209.08 million05/01/2024$3.22$3.25+0.93%$3.37$3.15195,459 shs$195.26 million04/30/2024$3.18$3.22+1.26%$3.25$3.1582,410 shs$193.46 million04/29/2024$3.17$3.18+0.32%$3.34$3.16305,138 shs$191.05 million04/26/2024$3.19$3.17-0.63%$3.21$3.13140,590 shs$190.45 million04/25/2024$3.18$3.19+0.31%$3.21$3.07167,447 shs$191.66 million04/24/2024$3.16$3.18+0.63%$3.21$3.11152,249 shs$191.05 million04/23/2024$3.13$3.16+0.96%$3.32$3.14270,690 shs$189.85 million04/22/2024$3.15$3.13-0.63%$3.26$3.12479,013 shs$188.05 million04/19/2024$3.16$3.15-0.32%$3.30$3.10307,599 shs$189.25 million04/18/2024$3.47$3.16-8.93%$3.48$3.11636,210 shs$189.85 million04/17/2024$3.50$3.47-0.86%$3.63$3.47150,942 shs$208.48 million04/16/2024$3.53$3.50-0.85%$3.60$3.40222,663 shs$210.28 million04/15/2024$3.74$3.53-5.61%$3.77$3.53214,885 shs$212.08 million04/12/2024$3.89$3.74-3.86%$3.93$3.70184,175 shs$224.70 million04/11/2024$3.71$3.89+4.85%$3.93$3.70218,695 shs$233.71 million04/10/2024$3.84$3.71-3.39%$3.83$3.61197,459 shs$222.90 million04/09/2024$3.89$3.84-1.29%$3.97$3.80216,849 shs$230.71 million04/08/2024$3.85$3.89+1.04%$3.99$3.86143,024 shs$233.71 millionKiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything.04/05/2024$3.84$3.85+0.26%$3.93$3.73138,122 shs$231.31 million04/04/2024$3.91$3.84-1.79%$4.06$3.82163,251 shs$230.71 million04/03/2024$3.79$3.91+3.17%$3.92$3.75155,494 shs$234.91 million04/02/2024$4.01$3.79-5.49%$4.03$3.77235,845 shs$227.70 million04/01/2024$4.05$4.01-0.99%$4.05$3.85246,136 shs$240.92 million03/29/2024$4.05$4.05$4.28$4.01511,581 shs$243.32 million03/28/2024$4.10$4.05-1.22%$4.28$4.01511,355 shs$234.54 million03/27/2024$3.75$4.10+9.33%$4.28$3.70600,099 shs$237.43 million03/26/2024$4.25$3.75-11.76%$4.26$3.311.39 million shs$217.16 million03/25/2024$4.30$4.25-1.16%$4.39$4.22352,178 shs$246.12 million03/22/2024$4.33$4.30-0.69%$4.43$4.30373,653 shs$249.01 million03/21/2024$4.15$4.33+4.34%$4.40$4.17323,481 shs$250.75 million03/20/2024$4.00$4.15+3.75%$4.21$3.99279,638 shs$240.33 million03/19/2024$3.98$4.00+0.50%$4.03$3.94292,922 shs$231.64 million03/18/2024$4.18$3.98-4.78%$4.23$3.98261,331 shs$230.48 million03/15/2024$4.09$4.18+2.20%$4.24$4.01204,066 shs$242.06 million03/14/2024$4.35$4.09-5.98%$4.35$4.06262,266 shs$236.85 million03/13/2024$4.12$4.35+5.58%$4.35$4.13254,372 shs$251.91 million03/12/2024$4.28$4.12-3.74%$4.31$4.10244,365 shs$238.59 million03/11/2024$4.37$4.28-2.06%$4.49$4.26371,493 shs$247.86 million03/08/2024$4.37$4.37$4.60$4.25338,502 shs$253.07 million03/07/2024$4.45$4.37-1.80%$4.57$4.37215,104 shs$253.07 million03/06/2024$4.35$4.45+2.30%$4.51$4.28341,592 shs$257.70 million03/05/2024$4.48$4.35-2.90%$4.56$4.32520,901 shs$251.91 million03/04/2024$4.64$4.48-3.45%$5.09$4.43748,337 shs$259.44 million03/01/2024$4.31$4.64+7.66%$4.74$4.32732,053 shs$268.70 million02/29/2024$4.17$4.31+3.36%$4.44$4.16461,991 shs$249.59 million Related Companies: OVID Stock Chart ATHA Stock Chart ACIU Stock Chart BMEA Stock Chart PRME Stock Chart RGNX Stock Chart CRGX Stock Chart HLVX Stock Chart ITOS Stock Chart TSHA Stock Chart Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABOS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.